ScienceDex / Researcher record
Tran, Dat Quang
- Oryn Therapeutics, LLC (no department on record)
From the FY2015 NIH awards this investigator leads as contact PI. The department is the award's.
NIH Funding · FY2015
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2015 | $1,142,534 | 1 | #5,826 |
| 2016 | $352,749 | 1 | #23,145 |
| 2019 | $284,978 | 1 | #31,110 |
| 2021 | $991,551 | 1 | #9,397 |
| 2022 | $983,348 | 1 | #10,058 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2015 · selected1 record
- FY20161 record
- FY20191 record
- FY20211 record
- FY20221 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2015 award records by amount
NIH award records listing Tran, Dat Quang as a PI. Multi-PI records show the full award amount for context.
- 1R44AR068833-01R44Contact PIFirst-in-Class Macrocyclic Peptide Therapeutic For Rheumatoid Arthritis$1.1Maward amount
Award organization
Organizations that administered FY2015 awards listing Tran, Dat Quang as a PI.
FY2015 award administered by Oryn Therapeutics, LLC ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardOryn Therapeutics, LLC
- 2015$500K Cumulative Funding
- 2015$1M Cumulative Funding
- 2015Entered Top 50% NationallyRanked #5826
- 2021$2M Cumulative Funding